Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash from Financing Activities (2016 - 2025)

Lipocine's Cash from Financing Activities history spans 13 years, with the latest figure at $141334.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities changed N/A year-over-year to $141334.0; the TTM value through Sep 2025 reached $358774.0, up 75.83%, while the annual FY2024 figure was $209340.0, 48.26% down from the prior year.
  • Cash from Financing Activities reached $141334.0 in Q3 2025 per LPCN's latest filing, down from $217440.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $29.4 million in Q1 2021 to a low of -$1.5 million in Q2 2022.
  • Average Cash from Financing Activities over 5 years is $1.7 million, with a median of -$5900.0 recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: tumbled 118.41% in 2021, then soared 956904.55% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$838463.0 in 2021, then soared by 99.3% to -$5900.0 in 2022, then rose by 10.19% to -$5299.0 in 2023, then skyrocketed by 4203.42% to $217440.0 in 2024, then tumbled by 35.0% to $141334.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Cash from Financing Activities are $141334.0 (Q3 2025), $217440.0 (Q2 2024), and -$8100.0 (Q1 2024).